FDA Inspection
CMIC CMO USA CorporationFDA Inspection 1207736 - CMIC CMO USA Corporation - March 31, 2023
Record Details
This FDA Inspection record concerns CMIC CMO USA Corporation, with an inspection on March 31, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8446a8c2-0503-4338-88a0-78fa95d7e13e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1207736
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of CMIC CMO USA Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 2, 2024 | Not classified | New Jersey District Office | |
| May 4, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 11, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CMIC CMO USA Corporation
- FDA Inspection 1244346 - 2024-07-02
- FDA Inspection 1141200 - 2021-05-04
- FDA Inspection 1037369 - 2018-01-11
- FDA Inspection 913702 - 2015-02-13
- FDA Inspection 858664 - 2013-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.